Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.84 |
| ▸ | ABAT | P80404 | 1/20 | 0.84 |
| ▸ | ESR1 | P03372 | 2/20 | 0.58 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.50 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.50 |
| ▸ | MMP3 | P08254 | 1/20 | 0.48 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21908191 | 1.00 | ALDH5A1 (0.84) | ALDH5A1ABATESR1ESR2KDM4E | |
| 4-Hydroxybenzaldehyde SCHEMBL37193 | 0.92 | — | — | |
| 4-Hydroxybenzaldehyde SCHEMBL19328157 | 0.92 | ALDH5A1 (1.00) | ALDH5A1ABATESR1ESR2KDM4E | |
| 4-Hydroxybenzaldehyde SCHEMBL30290836 | 0.89 | ALDH5A1 (0.94) | ALDH5A1ABATESR1ESR2KDM4E | |
| 4-Hydroxybenzaldehyde SCHEMBL29153364 | 0.89 | ALDH5A1 (0.94) | ALDH5A1ABATESR1ESR2KDM4E | |
| 4-Hydroxybenzaldehyde SCHEMBL28981620 | 0.89 | ALDH5A1 (0.94) | ALDH5A1ABATESR1ESR2KDM4E | |
| 4-Hydroxybenzaldehyde SCHEMBL2187647 | 0.89 | ALDH5A1 (0.94) | ALDH5A1ABATESR1ESR2KDM4E | |
| 4-Hydroxybenzaldehyde SCHEMBL5161739 | 0.89 | ALDH5A1 (0.94) | ALDH5A1ABATESR1ESR2KDM4E | |
| 4-Hydroxybenzaldehyde SCHEMBL28498005 | 0.89 | ALDH5A1 (0.94) | ALDH5A1ABATESR1ESR2KDM4E | |
| 4-Hydroxybenzaldehyde SCHEMBL29889847 | 0.89 | ALDH5A1 (0.94) | ALDH5A1ABATESR1ESR2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7265146-B2 | Integrin receptor inhibitors | GENENTECH, INC. (US) | 2007-09-04 | — | — | US | claimed |
| EP-1620392-B1 | HYDROXY-BIPHENYL-CARBALDEHYDE OXIME DERIVATIVES AND THEIR USE AS ESTROGENIC AGENTS | WYETH CORP (US) | 2007-06-27 | — | — | EP | claimed |
| US-20050187284-A1 | Integrin receptor inhibitors | GENENTECH, INC. (US) | 2005-08-25 | — | — | US | claimed |
| EP-1330430-A2 | INTEGRIN RECEPTOR INHIBITORS | GENENTECH, INC. (US) | 2003-07-30 | — | — | EP | claimed |
| US-20020035104-A1 | Integrin receptor inhibitors | GENENTECH, INC. | 2002-03-21 | — | — | US | claimed |
| WO-2002016313-A2 | INTEGRIN RECEPTOR INHIBITORS | GENENTECH, INC. (US) | 2002-02-28 | — | — | WO | claimed |
| US-6177500-B1 | CONTAINING A P-OXYBENZOYL UNIT (A) AND A 4'-OXYBIPHENYL-4-CARBONYL UNIT (B) AND 1 TO 400 PARTS BY WEIGHT OF AN INORGANIC FILLER. | SUMITOMO CEMICAL COMPANY, LIMITED (JP) | 2001-01-23 | — | — | US | claimed |
| JP-11029699-A | — | — | None | — | — | JP | disclosed |
| US-20250170283-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS | LANTHEUS MEDICAL IMAGING, INC. (US) | 2025-05-29 | — | — | US | disclosed |
| WO-2024226603-A1 | THERAPEUTIC COMPOUNDS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2024-10-31 | — | — | WO | disclosed |
| US-20240100199-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS | LANTHEUS MEDICAL IMAGING, INC. (US) | 2024-03-28 | — | — | US | disclosed |
| US-11744906-B2 | Compositions, methods, and systems for the synthesis and use of imaging agents | LANTHEUS MEDICAL IMAGING, INC. (US) | 2023-09-05 | — | — | US | disclosed |
| CN-107619432-B | Glycopeptide derivative and pharmaceutically acceptable salt, preparation method and application thereof | 上海来益生物药物研究开发中心有限责任公司 | 2023-03-17 | — | — | CN | disclosed |
| WO-1998055473-A1 | POLYMERISABLE, OPTICALLY ACTIVE DIOXOLANE DIESTERS | ROLIC AG (CH) | 1998-12-10 | — | — | WO | disclosed |
| WO-1994018229-A1 | 1,2,4-TRIAZINONE DERIVATIVES AND THEIR USE IN THERAPY | FISONS CORPORATION (US) | 1994-08-18 | — | — | WO | disclosed |
| US-4950809-A | REACTING ARYL KETONE OR ALDEHYDE WITH PERACETIC ACID | RHONE-POULENC CHIMIE (FR) | 1990-08-21 | — | — | US | disclosed |
| US-4613619-A | Anti-arrhythmic amino-alcohols | AKZO N.V. (NL) | 1986-09-23 | — | — | US | disclosed |
| EP-0155721-A1 | Novel anti-arrhythmic amino-alcohols | AKZO N.V. (NL) | 1985-09-25 | — | — | EP | disclosed |
| US-4071681-A | Process for preparing beta-lactam antibiotic substances | SANKYO COMPANY LIMITED (JA) | 1978-01-31 | — | — | US | disclosed |
| US-4016155-A | Process for preparing cephalosporin derivatives | SANKYO COMPANY LIMITED (JA) | 1977-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250170283-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS | FABP3, TNNI3, TNNT2 | ALDH5A1 2948/4885ABAT 2794/4885ESR1 3904/4885 |
| US-20020035104-A1 | Integrin receptor inhibitors | ITGB1, ITGA1, ITGA4 | ALDH5A1 4683/4885ABAT 4802/4885ESR1 1516/4885 |
| US-20240100199-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS | FABP3, TNNI3, TNNT2 | ALDH5A1 2948/4885ABAT 2794/4885ESR1 3904/4885 |
| US-20050187284-A1 | Integrin receptor inhibitors | ITGA4, ITGB4, ITGB1 | ALDH5A1 4753/4885ABAT 4738/4885ESR1 1137/4885 |
| US-11744906-B2 | Compositions, methods, and systems for the synthesis and use of imaging agents | FABP3, TNNI3, TNNT2 | ALDH5A1 2948/4885ABAT 2794/4885ESR1 3904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.